Influence of gut microbiota on the development of most prevalent neurodegenerative dementias and the potential effect of probiotics in elderly: A scoping review
Open Access
- 18 October 2023
- journal article
- review article
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 195 (2) , e32959
Abstract
Dementia is one of today's greatest public health challenges. Its high socio‐economic impact and difficulties in diagnosis and treatment are of increasing concern to an aging world population. In recent years, the study of the relationship between gut microbiota and different neurocognitive disorders has gained a considerable interest. Several studies have reported associations between gut microbiota dysbiosis and some types of dementia. Probiotics have been suggested to restore dysbiosis and to improve neurocognitive symptomatology in these dementias. Based on these previous findings, the available scientific evidence on the gut microbiota in humans affected by the most prevalent dementias, as well as the probiotic trials conducted in these patients in recent years, have been here reviewed. Decreased concentrations of short‐chain fatty acids (SCFA) and other bacterial metabolites appear to play a major role in the onset of neurocognitive symptoms in Alzheimer disease (AD) and Parkinson disease dementia (PDD). Increased abundance of proinflammatory taxa could be closely related to the more severe clinical symptoms in both, as well as in Lewy Bodies dementia. Important lack of information was noted in Frontotemporal dementia behavioral variant. Moreover, geographical differences in the composition of the gut microbiota have been reported in AD. Some potential beneficial effects of probiotics in AD and PDD have been reported. However, due to the controversial results further investigations are clearly necessary.Keywords
Funding Information
- Agència de Gestió d'Ajuts Universitaris i de Recerca (FI_B00314)
- Ministerio de Ciencia e Innovación (PID2019‐103888RB‐I00)
This publication has 91 references indexed in Scilit:
- Probiotic normalization of Candida albicans in schizophrenia: A randomized, placebo-controlled, longitudinal pilot studyBrain, Behavior, and Immunity, 2017
- Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderlyNeurobiology of Aging, 2017
- Human gut microbiota: the links with dementia developmentProtein & Cell, 2016
- Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled TrialFrontiers in Aging Neuroscience, 2016
- Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controlsParkinsonism & Related Disorders, 2016
- Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer diseaseNutrition Reviews, 2016
- Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow‐up studyAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2016
- Neuroinflammation in Lewy body dementiaParkinsonism & Related Disorders, 2015
- Colonic bacterial composition in Parkinson's diseaseMovement Disorders, 2015
- Gut microbiota are related to Parkinson's disease and clinical phenotypeMovement Disorders, 2014